Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 13, 2012 - Issue 6
Submit an article Journal homepage
816
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Treatment options for chronic myeloid leukemia

Maria Florencia TanakaBaylor College of Medicine, Hematology/Oncology Department, 1709 Dryden Rd, Room 574, Houston, TX 77030, USA
, MD,
Hagop KantarjianUT MD Anderson Cancer Center, Leukemia Department, 1515 Holcombe Blvd, Unit 428, Houston, TX 77030, [email protected]
, MD,
Jorge CortesUT MD Anderson Cancer Center, Leukemia Department, 1515 Holcombe Blvd, Unit 428, Houston, TX 77030, USA
, MD,
Maro OhanianThe University of Texas MD, Anderson Cancer Center, John Mendelsohn Faculty Center (FC4.3017), 1515 Holcombe Blvd. Unit 0428 Houston, TX 77030, United States of America+(713) 794-5579 office; [email protected]
, MD &
Elias JabbourUT MD Anderson Cancer Center, Leukemia Department, 1515 Holcombe Blvd, Unit 428, Houston, TX 77030, USA
, MD
Pages 815-828 | Published online: 19 Mar 2012

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Anna Kaltenboeck, Genia Long, Eleanor Hayes-Larson & Gilberto de Lima Lopes. (2013) Assessing the impact of substandard copy medicines in developing countries: the experience with imatinib copies. Expert Review of Clinical Pharmacology 6:6, pages 691-701.
Read now
Yusuf Baran & Guray Saydam. (2012) Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia. Journal of Blood Medicine 3, pages 139-150.
Read now

Articles from other publishers (10)

Bercin Tarlan & Hayyam Kiratli. 2019. Clinical Ophthalmic Oncology. Clinical Ophthalmic Oncology 365 377 .
Wen-Jun Wang, Chao-Feng Zheng, Zhuang Liu, Yan-Hong Tan, Xiu-Hua Chen, Bin-Liang Zhao, Guo-Xia Li, Zhi-Fang Xu, Fang-Gang Ren, Yao-Fang Zhang, Jian-Mei Chang & Hong-Wei Wang. (2018) Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression. European Journal of Haematology 101:3, pages 291-296.
Crossref
SHENG-LAN GONG, MENG-QIAO GUO, GU-SHENG TANG, CHUN-LING ZHANG, HUI-YING QIU, XIAO-XIA HU & JIAN-MIN YANG. (2016) Fusion of platelet-derived growth factor receptor β to CEV14 gene in chronic myelomonocytic leukemia: A case report and review of the literature. Oncology Letters 11:1, pages 770-774.
Crossref
David Gurrea Salas, Ingmar Glauche, Josephine T. Tauer, Christian Thiede & Meinolf Suttorp. (2015) Can prognostic scoring systems for chronic myeloid leukemia as established in adults be applied to pediatric patients?. Annals of Hematology 94:8, pages 1363-1371.
Crossref
Chung-Pu Wu, Sung-Han Hsiao, Ching-Ya Su, Shi-Yu Luo, Yan-Qing Li, Yang-Hui Huang, Chia-Hung Hsieh & Chiun-Wei Huang. (2014) Human ATP-Binding Cassette transporters ABCB1 and ABCG2 confer resistance to CUDC-101, a multi-acting inhibitor of histone deacetylase, epidermal growth factor receptor and human epidermal growth factor receptor 2. Biochemical Pharmacology 92:4, pages 567-576.
Crossref
Hayyam Kiratli & Bercin Tarlan. 2014. Clinical Ophthalmic Oncology. Clinical Ophthalmic Oncology 319 330 .
Craig T. Wallington‐Beddoe, Kenneth F. Bradstock & Linda J. Bendall. (2013) Oncogenic properties of sphingosine kinases in haematological malignancies. British Journal of Haematology 161:5, pages 623-638.
Crossref
Verena Gotta, Thierry Buclin, Chantal Csajka & Nicolas Widmer. (2013) Systematic Review of Population Pharmacokinetic Analyses of Imatinib and Relationships With Treatment Outcomes. Therapeutic Drug Monitoring 35:2, pages 150-167.
Crossref
Lee M. GravesJames S. DuncanMartin C. WhittleGary L. Johnson. (2013) The dynamic nature of the kinome. Biochemical Journal 450:1, pages 1-8.
Crossref
Kim Dao, Dana Védy, José Lopez, Olivier Staneczek, Thierry Buclin & Françoise Livio. (2012) Imatinib-induced dose-dependent interstitial lung disease successfully switched to nilotinib: a case report with concentration exposure data. International Journal of Hematology 97:2, pages 299-300.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.